Action of angiotensin receptor subtypes on the renal tubules and vasculature: Implications for volume homeostasis and atherosclerosis

被引:14
作者
Zitnay, C [1 ]
Siragy, HM [1 ]
机构
[1] Univ Virginia, Hlth Sci Ctr, Dept Med, Charlottesville, VA 22908 USA
关键词
angiotensin TT; AT-1; receptor; AT-2; kidney; atherosclerosis;
D O I
10.1159/000057397
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Angiotensin-II (ANG-II) is a potent endocrine and paracrine hormone that functions in humans through two distinct G-protein-coupled transmembrane receptor subtypes (AT-1 and AT-2). ANG-IT is found in nearly all tissues of the body including the brain, heart, kidneys, gonads, and gastrointestinal tract. Just as it is found in nearly every organ system of the body, so is it involved in an array of physiologic processes from fetal development to blood pressure control. ANG-II regulates blood pressure by controlling sodium reabsorption in the proximal tubule, altering the glomerular filtration rate and renal blood flow, and by modifying the production and release of aldosterone in the adrenal gland. Additionally, ANG-II is involved in several pathologic processes including the development of hypertension, cardiomyopathy, atherosclerosis, and diabetic nephropathy. It is able to exert influences in these widely varying processes by working together with multiple different second messenger systems including the MAP kinase pathway, nitric oxide production, and phospholipase C and D, and several arachidonic acid metabolites. This paper is a review of the current knowledge of ANG-II and its receptors in health and disease.
引用
收藏
页码:362 / 370
页数:9
相关论文
共 93 条
  • [1] ADLER S, 1994, J AM SOC NEPHROL, V5, P1165
  • [2] Pharmacological modulation of spontaneous renal blood flow dynamics
    Ajikobi, DO
    Novak, P
    Salevsky, FC
    Cupples, WA
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1996, 74 (08) : 964 - 972
  • [3] ALCORN D, 1996, CLIN EXP PHARM PH S3, V3, P88
  • [4] ANGIOTENSIN INCREASES INOSITOL TRISPHOSPHATE AND CALCIUM IN VASCULAR SMOOTH-MUSCLE
    ALEXANDER, RW
    BROCK, TA
    GIMBRONE, MA
    RITTENHOUSE, SE
    [J]. HYPERTENSION, 1985, 7 (03) : 447 - 451
  • [5] ALLEN A, 1987, J COMP NEUROL, V312, P291
  • [6] ANGIOTENSIN-II RECEPTOR-BINDING ASSOCIATED WITH NIGROSTRIATAL DOPAMINERGIC-NEURONS IN HUMAN BASAL GANGLIA
    ALLEN, AM
    MACGREGOR, DP
    CHAI, SY
    DONNAN, GA
    KACZMARCZYK, S
    RICHARDSON, K
    KALNINS, R
    IRETON, J
    MENDELSOHN, FAO
    [J]. ANNALS OF NEUROLOGY, 1992, 32 (03) : 339 - 344
  • [7] Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole
    Arima, S
    Endo, Y
    Yaoita, H
    Omata, K
    Ogawa, S
    Tsunoda, K
    Abe, M
    Takeuchi, K
    Abe, K
    Ito, S
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (11) : 2816 - 2823
  • [8] REDUCED GLOMERULAR ANGIOTENSIN-II RECEPTOR DENSITY IN EARLY UNTREATED DIABETES-MELLITUS IN THE RAT
    BALLERMANN, BJ
    SKORECKI, KL
    BRENNER, BM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1984, 247 (01): : F110 - F116
  • [9] IDENTIFICATION AND CHARACTERIZATION OF ANGIOTENSIN-II RECEPTOR SUBTYPES IN HUMAN BRAIN
    BARNES, JM
    STEWARD, LJ
    BARBER, PC
    BARNES, NM
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 230 (03) : 251 - 258
  • [10] Aortic collagen, aortic stiffness, and AT(1) receptors in experimental and human hypertension
    Benetos, A
    Safar, ME
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1996, 74 (07) : 862 - 866